IVAN ROSAS to Fibrosis
This is a "connection" page, showing publications IVAN ROSAS has written about Fibrosis.
Connection Strength
0.669
-
PIK-III exerts anti-fibrotic effects in activated fibroblasts by regulating p38 activation. PLoS One. 2024; 19(9):e0306624.
Score: 0.200
-
NEDD9 targets COL3A1 to promote endothelial fibrosis and pulmonary arterial hypertension. Sci Transl Med. 2018 06 13; 10(445).
Score: 0.130
-
TRIOBP modulates ?-catenin signaling by regulation of miR-29b in idiopathic pulmonary fibrosis. Cell Mol Life Sci. 2023 Dec 29; 81(1):13.
Score: 0.048
-
Single-Cell RNA Sequencing Provides New Insights into Therapeutic Roles of Thyroid Hormone in Idiopathic Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2023 10; 69(4):456-469.
Score: 0.047
-
Progressive Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis. Am J Respir Crit Care Med. 2023 01 15; 207(2):211-214.
Score: 0.045
-
Saracatinib, a Selective Src Kinase Inhibitor, Blocks Fibrotic Responses in Preclinical Models of Pulmonary Fibrosis. Am J Respir Crit Care Med. 2022 12 15; 206(12):1463-1479.
Score: 0.044
-
TRIB3 Mediates Fibroblast Activation and Fibrosis though Interaction with ATF4 in IPF. Int J Mol Sci. 2022 Dec 11; 23(24).
Score: 0.044
-
Fulminant lung fibrosis in non-resolvable COVID-19 requiring transplantation. EBioMedicine. 2022 Dec; 86:104351.
Score: 0.044
-
Fibroblasts positive for meflin have anti-fibrotic properties in pulmonary fibrosis. Eur Respir J. 2021 12; 58(6).
Score: 0.041
-
A YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditions. Sci Rep. 2015 Dec 15; 5:18277.
Score: 0.027